ESMO Congress 2019

General session-ESMO 2019

Off-label therapies: what is their future?

Many studies presented at the Congress hint at promising treatments for rare sarcomas but access to effective treatments remains a challenge 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.